(Q31013566)

28 June 2017

1 reference

title

Serotonergic mechanisms in Parkinson's disease: opposing results from preclinical and clinical data (English)

1 reference

28 June 2017

0 references

B Scholtissen

1

1 reference

28 June 2017

F R J Verhey

series ordinal

2

1 reference

28 June 2017

H W M Steinbusch

series ordinal

3

1 reference

28 June 2017

A F G Leentjens

series ordinal

4

1 reference

28 June 2017

language of work or name

1 reference

27 October 2005

1 reference

Journal of Neural Transmission

28 June 2017

published in

1 reference

28 June 2017

volume

113

1 reference

28 June 2017

issue

1

1 reference

28 June 2017

page(s)

59-73

1 reference

Serotonergic mechanisms in Parkinson's disease

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0368-3

Parkinson's disease: Modification by 5-hydroxytryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0368-3

Depression and Parkinson's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0368-3

Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0368-3

Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0368-3

Serotonergic sprouting in primate MTP-induced hemiparkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0368-3

Rapid deterioration in patients with parkinsonism following tryptophan-pyridoxine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0368-3

Biochemical aspects of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0368-3

Altered serotonin metabolism in depressed patients with parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0368-3

Serotonergic dysfunction in depression associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0368-3

Psychosis in advanced Parkinson's disease: treatment with ondansetron, a 5-HT3 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-005-0368-3

Behavioral effects of 5-HT2C receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.

21 January 2018

1 reference

12 December 2020

Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain

1 reference

12 December 2020

Central serotonin metabolism and frequency of depression

1 reference

12 December 2020

Post-synaptic 5-HT1A and 5-HT2A receptors are increased in Parkinson's disease neocortex

1 reference

12 December 2020

1 reference

12 December 2020

Tryptophan depletion, executive functions, and disinhibition in aggressive, adolescent males.

1 reference

12 December 2020

Serotonin 5-HT(1A) receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys

1 reference

12 December 2020

Effect of ritanserin, a highly selective 5-HT2 receptor antagonist, on Parkinson's disease

1 reference

12 December 2020

In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.

1 reference

12 December 2020

Dopamine receptor agonists regulate levels of the serotonin 5-HT2A receptor and its mRNA in a subpopulation of rat striatal neurons

1 reference

12 December 2020

Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.

1 reference

12 December 2020

Effects of acute tryptophan depletion on mood and cortisol release in first-degree relatives of type I and type II bipolar patients and healthy matched controls.

1 reference

12 December 2020

Tryptophan malabsorption in levodopa-treated parkinsonian patients. Effect of tryptophan on mental disturbances

1 reference

12 December 2020

Serotonin, dopamine, and motor effects in Parkinson's disease

1 reference

12 December 2020

Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum

1 reference

12 December 2020

Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review

1 reference

12 December 2020

Role of serotonin(2C) receptors in the control of brain dopaminergic function

1 reference

12 December 2020

L-tryptophan administration in L-dopa-induced hallucinations in elderly Parkinsonian patients

1 reference

12 December 2020

Aggravation of parkinsonian tremor by cisapride

1 reference

12 December 2020

Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

1 reference

12 December 2020

Duration of illness and response to tryptophan in Parkinson's disease

1 reference

12 December 2020

Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway

1 reference

12 December 2020

Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers.

1 reference

12 December 2020

[123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain

1 reference

12 December 2020

The "serotonin hypothesis" for depression in Parkinson's disease

1 reference

12 December 2020

ACTH/Cortisol Involvement in the Serotonergic Disorder Affecting the Parkinsonian Brain

1 reference

12 December 2020

Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis

1 reference

12 December 2020

Does Nefazodone Improve Both Depression and Parkinson Disease? A Pilot Randomized Trial

1 reference

12 December 2020

Is the Ecstasy-induced ipsilateral rotation in 6-hydroxydopamine unilaterally lesioned rats dopamine independent?

1 reference

12 December 2020

Models of Parkinson's disease

1 reference

12 December 2020

Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation

1 reference

12 December 2020

A method for evaluating disability in patients with Parkinson's disease.

1 reference

12 December 2020

Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms

1 reference

12 December 2020

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

1 reference

12 December 2020

Serotonin-facilitated dopamine release in vivo: pharmacological characterization

1 reference

12 December 2020

Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects

1 reference

12 December 2020

Positron emission tomography of striatal serotonin transporters in Parkinson disease

1 reference

12 December 2020

6-hydroxy-dopamine induced degeneration of central monoamine neurons

1 reference

12 December 2020

In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's disease

1 reference

12 December 2020

L-tryptophan supplementation in Parkinson's disease

1 reference

12 December 2020

123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects

1 reference

12 December 2020

[123I]beta-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients

1 reference

12 December 2020

Depression in Parkinson's disease: conceptual issues and clinical challenges

1 reference

12 December 2020

Quetiapine attenuates levodopa-induced motor complications in rodent and primate parkinsonian models

1 reference

12 December 2020

SPECT imaging of dopamine and serotonin transporters with [123I]?-CIT. Binding kinetics in the human brain

1 reference

12 December 2020

Combined intrastriatal dopamine d1 and serotonin 5-ht2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats

1 reference

12 December 2020

Dopamine depletion abolishes apomorphine- and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats: a microdialysis study

1 reference

12 December 2020

Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge.

1 reference

12 December 2020

Dopamine action and disorders of neurotransmitter balance

1 reference

12 December 2020

1 reference

12 December 2020

Tryptophan depletion in normal volunteers produces selective impairments in learning and memory.

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine (Ecstasy) Inhibits Dyskinesia Expression and Normalizes Motor Activity in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Treated Primates

1 reference

12 December 2020

Diurnal variations in plasma concentrations of tryptophan, tyrosine, and other neutral amino acids: effect of dietary protein intake

1 reference

12 December 2020

A clinical study of methysergide in parkinsonism: Evidence against a serotonergic mechanism

1 reference

12 December 2020

Serotonergic 'vulnerability' in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram-responders

1 reference

12 December 2020

Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.

1 reference

12 December 2020

Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats

1 reference

12 December 2020

Serotonin(2C) receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: a combined dialysis and electrophysiological analysis in the rat

1 reference

12 December 2020

5-HT(2C) receptor antagonists enhance the behavioural response to dopamine D(1) receptor agonists in the 6-hydroxydopamine-lesioned rat

1 reference

12 December 2020

Rotational behavior induced by 8-hydroxy-DPAT, a putative 5HT-1A agonist, in 6-hydroxydopamine-lesioned rats

1 reference

12 December 2020

Aromatic L-amino acid decarboxylase is present in serotonergic fibers of the striatum of the rat. A double-labeling immunofluorescence study

1 reference

12 December 2020

8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release

1 reference

12 December 2020

Serotonergic mechanisms and extrapyramidal function in man.

1 reference

12 December 2020

Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors

1 reference

12 December 2020

The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used

1 reference

12 December 2020

Prolactin and cortisol responses to fenfluramine in Parkinson's disease.

1 reference

12 December 2020

Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders

1 reference

12 December 2020

Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects.

1 reference

12 December 2020

5-hydroxytryptamine (5-HT, serotonin) and Parkinson's disease - opportunities for novel therapeutics to reduce the problems of levodopa therapy

1 reference

12 December 2020

Defective 5-HT1 -Receptor-Mediated Neurotransmission in the Control of Growth Hormone Secretion in Parkinson’s Disease

1 reference

12 December 2020

Role of 5-HT(2C) receptors in the control of central dopamine function

1 reference

12 December 2020

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine

1 reference

12 December 2020

5-HT and motor control: a hypothesis

1 reference

12 December 2020

Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey

1 reference

12 December 2020

Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study

1 reference

12 December 2020

Rapid induction of serotonergic hyperinnervation in the adult rat striatum with extensive dopaminergic denervation

1 reference

12 December 2020

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

12 December 2020

1 reference

12 December 2020

Fenfluramine and Parkinson's disease

1 reference

12 December 2020

SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity

1 reference

12 December 2020

Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response

1 reference

12 December 2020

Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.

1 reference

12 December 2020

Parkinson's disease: mechanisms and models

1 reference

12 December 2020

Increased expression of 5HT2 receptor mRNA in rat striatum following 6-OHDA lesions of the adult nigrostriatal pathway

1 reference

12 December 2020

Ventilatory effects of tryptophan depletion in panic disorder: a preliminary report

1 reference

12 December 2020

10.1007/S00702-005-0368-3

Identifiers

DOI

1 reference

Dimensions Publication ID

28 June 2017

1041606456

0 references

1 reference